burcon – ein spekulativer play im nahrungsmittelsektor (Seite 749)
eröffnet am 23.07.08 16:33:28 von
neuester Beitrag 02.05.24 21:15:22 von
neuester Beitrag 02.05.24 21:15:22 von
Beiträge: 9.963
ID: 1.143.061
ID: 1.143.061
Aufrufe heute: 8
Gesamt: 592.572
Gesamt: 592.572
Aktive User: 0
ISIN: CA1208311029 · WKN: 157793 · Symbol: BNE
0,1765
EUR
-5,36 %
-0,0100 EUR
Letzter Kurs 09.05.24 Tradegate
Werte aus der Branche Biotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 8,1500 | +94,12 | |
| 17,870 | +48,18 | |
| 1,3300 | +30,51 | |
| 1,9750 | +27,42 | |
| 1,9800 | +26,11 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 10,105 | -18,38 | |
| 0,7000 | -20,45 | |
| 0,7215 | -21,52 | |
| 3,1400 | -22,28 | |
| 3,0200 | -77,81 |
Beitrag zu dieser Diskussion schreiben
Feedback
Meine natürlich am 1.4.2010 !!!(schon!!!)
burcons formaler gras-antrag musste aufgrund einiger kommentare durch die fda nochmal geändert werden nach der ursprünglichen einreichung im januar und wurde im februar erneut an die fda übersandt. mit schreiben vom 01.04. bestätigte die behörde nun förmlich den empfang des gras antrages...die sache verzögert sich also. das könnte imo der grund für den kursabsacker gewesen sein.
hier der o-text:
GRAS Notification Update - U.S. Patent Grants
VANCOUVER, Apr. 8, 2010 (Canada NewsWire Group) -- /CNW/ -- Burcon NutraScience Corporation (TSX - BU) ("Burcon" or the "Company") announces today that the Division of Biotechnology and GRAS Notice Review of the Center for Food Safety and Applied Nutrition of the Food and Drug Administration (the "FDA") has formally acknowledged receipt of Burcon's GRAS notification. Burcon's GRAS notification was filed in January 2010 and in response to comments from the FDA, it was modified and resubmitted in February 2010. In a letter dated April 1, 2010 the FDA has formally acknowledged receipt of the GRAS notification.
Burcon also reports that five previously announced notices of allowance received with respect to its U.S. patent applications have now proceeded to grant as United States patents by the United States Patent and Trademark Office. The first U.S. Patent - titled "Canola Protein Isolate Compositions" (US Patent No. 7,662,922) covers processes for the production of canola protein isolates whereby the resulting isolates are separated into their native underlying protein fractions. The second U.S. Patent - titled "Colour Reduction in Canola Protein Isolate" (US Patent No. 7,678,392) covers extraction procedures that improve the final colour profile of Puratein(R) canola protein isolate and Supertein(TM) canola protein isolate. The third U.S. Patent - titled "Process For Preparation of Canola Protein Isolates" (US Patent 7,682,646) covers an extraction procedure for the preparation of a highly refined Supertein(TM) canola protein isolate. The fourth U.S. Patent - titled "Production of Oilseed Protein Isolates" (US Patent 7,687,087) covers processes for the efficient production of Burcon's Puratein(R) canola protein isolate and Supertein(TM) canola protein isolate. The fifth U.S. Patent - titled "Protein Isolation Procedures for Reducing Phytic Acid" (US Patent 7,687,088) covers processes for reducing phytic acid in the production of protein isolates from oilseed meals.
Burcon now holds a total of 17 U.S. patents over its protein extraction technology and protein product uses. To-date, Burcon's patent portfolio consists of 120 issued patents in various countries, including the 17 issued U.S. patents noted above, and in excess of 225 additional pending patent applications, 70 of which are U.S. patent applications.
About Burcon NutraScience
Burcon is a leader in nutrition, health and wellness in the field of functional, renewable plant proteins. Since 1999, Burcon has developed a portfolio of composition, application, and process patents originating from our core protein extraction and purification technology. We are developing Puratein(R) and Supertein(TM) canola protein isolates with unique functional and nutritional attributes, and CLARISOY(TM), a revolutionary soy protein isolate which is 100% soluble and completely transparent in acidic solutions. Our team of highly specialized scientists and engineers work from our own research facility to develop and optimize environmentally sound technologies. To-date, our patent portfolio consists of 120 issued patents in various countries, including 17 issued U.S. patents, and in excess of 225 additional pending patent applications, 70 of which are U.S. patent applications.
ON BEHALF OF THE BOARD OF DIRECTORS
"Johann F. Tergesen"
Johann F. Tergesen
hier der o-text:
GRAS Notification Update - U.S. Patent Grants
VANCOUVER, Apr. 8, 2010 (Canada NewsWire Group) -- /CNW/ -- Burcon NutraScience Corporation (TSX - BU) ("Burcon" or the "Company") announces today that the Division of Biotechnology and GRAS Notice Review of the Center for Food Safety and Applied Nutrition of the Food and Drug Administration (the "FDA") has formally acknowledged receipt of Burcon's GRAS notification. Burcon's GRAS notification was filed in January 2010 and in response to comments from the FDA, it was modified and resubmitted in February 2010. In a letter dated April 1, 2010 the FDA has formally acknowledged receipt of the GRAS notification.
Burcon also reports that five previously announced notices of allowance received with respect to its U.S. patent applications have now proceeded to grant as United States patents by the United States Patent and Trademark Office. The first U.S. Patent - titled "Canola Protein Isolate Compositions" (US Patent No. 7,662,922) covers processes for the production of canola protein isolates whereby the resulting isolates are separated into their native underlying protein fractions. The second U.S. Patent - titled "Colour Reduction in Canola Protein Isolate" (US Patent No. 7,678,392) covers extraction procedures that improve the final colour profile of Puratein(R) canola protein isolate and Supertein(TM) canola protein isolate. The third U.S. Patent - titled "Process For Preparation of Canola Protein Isolates" (US Patent 7,682,646) covers an extraction procedure for the preparation of a highly refined Supertein(TM) canola protein isolate. The fourth U.S. Patent - titled "Production of Oilseed Protein Isolates" (US Patent 7,687,087) covers processes for the efficient production of Burcon's Puratein(R) canola protein isolate and Supertein(TM) canola protein isolate. The fifth U.S. Patent - titled "Protein Isolation Procedures for Reducing Phytic Acid" (US Patent 7,687,088) covers processes for reducing phytic acid in the production of protein isolates from oilseed meals.
Burcon now holds a total of 17 U.S. patents over its protein extraction technology and protein product uses. To-date, Burcon's patent portfolio consists of 120 issued patents in various countries, including the 17 issued U.S. patents noted above, and in excess of 225 additional pending patent applications, 70 of which are U.S. patent applications.
About Burcon NutraScience
Burcon is a leader in nutrition, health and wellness in the field of functional, renewable plant proteins. Since 1999, Burcon has developed a portfolio of composition, application, and process patents originating from our core protein extraction and purification technology. We are developing Puratein(R) and Supertein(TM) canola protein isolates with unique functional and nutritional attributes, and CLARISOY(TM), a revolutionary soy protein isolate which is 100% soluble and completely transparent in acidic solutions. Our team of highly specialized scientists and engineers work from our own research facility to develop and optimize environmentally sound technologies. To-date, our patent portfolio consists of 120 issued patents in various countries, including 17 issued U.S. patents, and in excess of 225 additional pending patent applications, 70 of which are U.S. patent applications.
ON BEHALF OF THE BOARD OF DIRECTORS
"Johann F. Tergesen"
Johann F. Tergesen
Was soll man dazu noch sagen:
GRAS Notification Update - U.S. Patent Grants
GRAS Notification Update - U.S. Patent Grants
VANCOUVER, Apr. 8, 2010 (Canada NewsWire Group) -- /CNW/ -- Burcon NutraScience Corporation (TSX - BU) ("Burcon" or the "Company") announces today that the Division of Biotechnology and GRAS Notice Review of the Center for Food Safety and Applied Nutrition of the Food and Drug Administration (the "FDA") has formally acknowledged receipt of Burcon's GRAS notification. Burcon's GRAS notification was filed in January 2010 and in response to comments from the FDA, it was modified and resubmitted in February 2010. In a letter dated April 1, 2010 the FDA has formally acknowledged receipt of the GRAS notification.
Burcon also reports that five previously announced notices of allowance received with respect to its U.S. patent applications have now proceeded to grant as United States patents by the United States Patent and Trademark Office. The first U.S. Patent - titled "Canola Protein Isolate Compositions" (US Patent No. 7,662,922) covers processes for the production of canola protein isolates whereby the resulting isolates are separated into their native underlying protein fractions. The second U.S. Patent - titled "Colour Reduction in Canola Protein Isolate" (US Patent No. 7,678,392) covers extraction procedures that improve the final colour profile of Puratein(R) canola protein isolate and Supertein(TM) canola protein isolate. The third U.S. Patent - titled "Process For Preparation of Canola Protein Isolates" (US Patent 7,682,646) covers an extraction procedure for the preparation of a highly refined Supertein(TM) canola protein isolate. The fourth U.S. Patent - titled "Production of Oilseed Protein Isolates" (US Patent 7,687,087) covers processes for the efficient production of Burcon's Puratein(R) canola protein isolate and Supertein(TM) canola protein isolate. The fifth U.S. Patent - titled "Protein Isolation Procedures for Reducing Phytic Acid" (US Patent 7,687,088) covers processes for reducing phytic acid in the production of protein isolates from oilseed meals.
Burcon now holds a total of 17 U.S. patents over its protein extraction technology and protein product uses. To-date, Burcon's patent portfolio consists of 120 issued patents in various countries, including the 17 issued U.S. patents noted above, and in excess of 225 additional pending patent applications, 70 of which are U.S. patent applications.
About Burcon NutraScience
Wenn ich das richtig verstanden habe, musste BU die Unterlagen im Februar geändert erneut einreichen.(Schande!!) Und jetzt am 1.4.09 bestätigt die FDA doch tatsächlich schon den offiziellen Eingang der Unterlagen bzw. erklären nun, dass sie keine formellen Einwände mehr haben. Damit wäre Deine die 90-tagefrist Campi am 19.4.10 schon mal kaputt! Sie können es einfach nicht!!!!!
GRAS Notification Update - U.S. Patent Grants
GRAS Notification Update - U.S. Patent Grants
VANCOUVER, Apr. 8, 2010 (Canada NewsWire Group) -- /CNW/ -- Burcon NutraScience Corporation (TSX - BU) ("Burcon" or the "Company") announces today that the Division of Biotechnology and GRAS Notice Review of the Center for Food Safety and Applied Nutrition of the Food and Drug Administration (the "FDA") has formally acknowledged receipt of Burcon's GRAS notification. Burcon's GRAS notification was filed in January 2010 and in response to comments from the FDA, it was modified and resubmitted in February 2010. In a letter dated April 1, 2010 the FDA has formally acknowledged receipt of the GRAS notification.
Burcon also reports that five previously announced notices of allowance received with respect to its U.S. patent applications have now proceeded to grant as United States patents by the United States Patent and Trademark Office. The first U.S. Patent - titled "Canola Protein Isolate Compositions" (US Patent No. 7,662,922) covers processes for the production of canola protein isolates whereby the resulting isolates are separated into their native underlying protein fractions. The second U.S. Patent - titled "Colour Reduction in Canola Protein Isolate" (US Patent No. 7,678,392) covers extraction procedures that improve the final colour profile of Puratein(R) canola protein isolate and Supertein(TM) canola protein isolate. The third U.S. Patent - titled "Process For Preparation of Canola Protein Isolates" (US Patent 7,682,646) covers an extraction procedure for the preparation of a highly refined Supertein(TM) canola protein isolate. The fourth U.S. Patent - titled "Production of Oilseed Protein Isolates" (US Patent 7,687,087) covers processes for the efficient production of Burcon's Puratein(R) canola protein isolate and Supertein(TM) canola protein isolate. The fifth U.S. Patent - titled "Protein Isolation Procedures for Reducing Phytic Acid" (US Patent 7,687,088) covers processes for reducing phytic acid in the production of protein isolates from oilseed meals.
Burcon now holds a total of 17 U.S. patents over its protein extraction technology and protein product uses. To-date, Burcon's patent portfolio consists of 120 issued patents in various countries, including the 17 issued U.S. patents noted above, and in excess of 225 additional pending patent applications, 70 of which are U.S. patent applications.
About Burcon NutraScience
Wenn ich das richtig verstanden habe, musste BU die Unterlagen im Februar geändert erneut einreichen.(Schande!!) Und jetzt am 1.4.09 bestätigt die FDA doch tatsächlich schon den offiziellen Eingang der Unterlagen bzw. erklären nun, dass sie keine formellen Einwände mehr haben. Damit wäre Deine die 90-tagefrist Campi am 19.4.10 schon mal kaputt! Sie können es einfach nicht!!!!!
Antwort auf Beitrag Nr.: 39.289.901 von og6 am 07.04.10 19:37:40hab nur die Hälfte raus!
Trading Spotlight
Antwort auf Beitrag Nr.: 39.289.906 von metallix am 07.04.10 19:38:11Ja ! Zudem im Plus - was auch nicht selbstverständlich ist und Steuerfrei was jetzt fast logisch war.
Antwort auf Beitrag Nr.: 39.289.690 von awsx am 07.04.10 19:10:08@awsx
Hier bist Du gut aufgehoben
...fühl mich hier sicherer als auf der Bank....
bin ja auch schon seit "2005/2006 dabei"
Gruss,
Metallix
Bist Du noch bei Sabina Silver investiert ???
Hier bist Du gut aufgehoben
...fühl mich hier sicherer als auf der Bank....
bin ja auch schon seit "2005/2006 dabei"
Gruss,
Metallix
Bist Du noch bei Sabina Silver investiert ???
Antwort auf Beitrag Nr.: 39.289.690 von awsx am 07.04.10 19:10:08Wobei bei beiden Werten das Ende der Fahnenstange noch nicht erreicht ist. Sunwin habe ich auch auch meiner WL. Noch kein Einstieg erfolgt.
Antwort auf Beitrag Nr.: 39.289.508 von og6 am 07.04.10 18:52:03Hallo
Ich habe den Wert schon länger auf der Watchlist gehabt aber bisher nur hinterher geschaut. Nachdem mir Sunwin ein schnellen Zwischengewinn einbrachte wollte ich die liquiden Mittel nicht verstauben lassen.
Weiterhin wollte ich für den Sommer nicht weiter auf "Schneeräumdienste und Regenschirmproduzenten" setzen und diversifiziere quasi mit Burcon etwas mein Depot.
....ich hoffe die Idee war gut .
Ich habe den Wert schon länger auf der Watchlist gehabt aber bisher nur hinterher geschaut. Nachdem mir Sunwin ein schnellen Zwischengewinn einbrachte wollte ich die liquiden Mittel nicht verstauben lassen.
Weiterhin wollte ich für den Sommer nicht weiter auf "Schneeräumdienste und Regenschirmproduzenten" setzen und diversifiziere quasi mit Burcon etwas mein Depot.
....ich hoffe die Idee war gut .
Na dann ein herzliches Willkommen den Neuen!
An AWSX: Hast aber den TR-Bericht nicht zu oft gelesen?
Ziehe mich gerade an dem Begriff "Kursschüben" hoch!(Wird von denen all zu gerne verwendet) Was ist denn der Hauptgrund, nach hoffe doch eingehender Recherche, für Dein Vertrauen in Burcon?
Wodurch bist Du auf Burcon jetzt aufmerksam geworden? Oder schon länger auf der Watchlist?
An AWSX: Hast aber den TR-Bericht nicht zu oft gelesen?
Ziehe mich gerade an dem Begriff "Kursschüben" hoch!(Wird von denen all zu gerne verwendet) Was ist denn der Hauptgrund, nach hoffe doch eingehender Recherche, für Dein Vertrauen in Burcon?
Wodurch bist Du auf Burcon jetzt aufmerksam geworden? Oder schon länger auf der Watchlist?
Durchsuchen
